Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  Cannabis Science Inc    

 SummaryNewsCompany 
Company
Cannabis Science, Inc. develops cannabis pharmaceutical products.It is at the forefront of cannabinoid research and development.The company works on phytocannabinoid science targeting critical illnesses and adheres to scientific methodologies to develop, produce, and commercialize... 
More about the company
Latest news on CANNABIS SCIENCE INC
02/24 CANNABIS SCIENCE : Announces Update on Proposed DPI Inhalation Device, CBD Infus..
02/21 CANNABIS SCIENCE : Crown Baus Capital Corp. Acquires 100-Acre Investment Partici..
02/17 CROWN BAUS CAPITAL CORP. : Acquires 100-Acre Investment Participation in Cannabi..
02/01 Marijuana Industry Pushing Toward Federal Acceptance, Expanded Research in 20..
01/25 CANNABIS SCIENCE : Distributors Sells Out of Initial Test Batch of CBIS Metered ..
01/10 Senate Banking Committee Could Pave the Way to a Bankable Marijuana Industry
01/10 CANNABIS SCIENCE, INC. (OTCMKTS : CBIS) Files An 8-K Entry into a Material Defin..
01/09 CANNABIS SCIENCE : Collaborative Research Agreement with Dana Farber Cancer Inst..
01/09 CANNABIS SCIENCE, INC. : Entry into a Material Definitive Agreement, Other Event..
01/06 CANNABIS SCIENCE : CBIS) and Dana Farber/Harvard Cancer Center (DF/HCC) Announce..
More news
Sector news : Bio Therapeutic Drugs
02/22 Genmab and J&J's cancer drug set for blockbuster sales this year
02/21 Icahn buys Bristol-Myers shares, adding to activist pressure
02/21DJBristol-Myers Expands Board, Boosts Buybacks Amid Activist Pressure
02/16 How Sanofi lost out to J&J in $30 billion battle for Actelion
02/14 Gilead challenges GSK with strong HIV drug data
More sector news : Bio Therapeutic Drugs
Advertisement
Managers
NameTitle
Raymond C. Dabney President, Chief Executive Officer & Director
Robert Kane Chief Operating Officer & Director
Benjamin C. K. Tam Chief Financial Officer, Secretary & Director
Richard Ogden Chief Scientific Officer
Allen A. Herman Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CANNABIS SCIENCE INC0
AMGEN, INC.19.01%128 555
GILEAD SCIENCES, INC.-3.13%92 143
CELGENE CORPORATION3.21%91 979
REGENERON PHARMACEUTIC..-1.67%38 296
ACTELION LTD22.45%28 792
More Results